BioXcel Therapeutics Company
Utilizes AI to identify and develop new applications for existing drugs or clinical candidates, focusing on neuroscience and immuno-oncology.
.png)
Industry:
Drug Repurposing
Total Funding:
Public (IPO 2018)
Headquarters:
USA
Founded Date:
2017
Employee Number:
100